Arhaus, a premium home-furnishing brand known for artisan-crafted products, reported results for its third quarter ended September 30, 2026. The report landed at a pivotal moment for the company, which is celebrating its 40th anniversary while navigating a soft housing market and a more cautious consumer backdrop. Investors are closely watching whether the brand's affluent customer base can sustain spending even as broader housing activity remains suppressed. In my view, the results reveal a clear tension: demand is accelerating at the front end of the business, but higher investments in marketing, technology, and new showrooms are weighing on near-term profitability. That dynamic makes this quarter an important gauge of how quickly order strength will convert into recognized revenue and restored margin leverage. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Arhaus posted record third-quarter net revenue of $368.1 million, up 6.8% from $344.6 million a year ago, though it came in about 1% below the consensus estimate of roughly $370.6 million. Net income fell 36% to $7.8 million, and GAAP EPS of $0.05 missed consensus expectations of approximately $0.08–$0.09. Adjusted EBITDA declined 12.3% to $27 million, within the company's guidance range, while its margin compressed 170 basis points to 7.4%.
Gross profit rose 8.2% to $144 million, and gross margin improved 50 basis points to 39.2%. The profit shortfall instead stemmed from SG&A expenses, which climbed 14.8% to $134.3 million on higher marketing, technology, and legal spending, plus a timing mismatch in variable compensation tied to strong written orders. Comparable written sales accelerated to 13.9%, while comparable delivered sales rose 2.6%. Arhaus ended the quarter with $318 million in cash, no long-term debt, and client deposits up 37.7% from year-end to about $325 million.
Investor reaction to Arhaus's report was relatively muted, with shares holding near the $13 level immediately after the release. The subdued response reflects a split interpretation of the quarter: the earnings miss was notable, but it was driven largely by spending that management frames as temporary rather than structural. Investors appeared to weigh the sharp acceleration in written orders and the raised revenue outlook against the weaker bottom line. Sentiment heading into the report had been constructive, with the stock having climbed significantly since its August report, which raised the bar for an upside surprise. The profit miss and the modest revenue shortfall tempered that enthusiasm even as demand metrics signaled improving momentum across the business.
Management raised its full-year revenue guidance to a range of $1.465 billion to $1.485 billion, up from $1.43–$1.47 billion, while leaving its profit and adjusted EBITDA outlook unchanged. The implied fourth quarter calls for meaningfully faster revenue growth and a step-up in delivered comparable sales, which will depend on the company's ability to convert its growing backlog of written orders into delivered revenue.
Several factors are worth watching next. First, the timing gap between written and delivered sales is expected to reverse in the fourth quarter, potentially restoring SG&A leverage. Second, management pointed to elevated legal, marketing, and technology costs that it expects to moderate over the coming quarters. Third, tariff exposure has been trimmed: the company now estimates annual tariff costs of roughly $30–$40 million, down from a prior $50–$60 million estimate, and October price increases are intended to offset residual cost pressure.
Operationally, investors should monitor fuel surcharges and ocean container costs, which management expects to persist into the first half of 2027, as well as the delayed rollout of its new ERP and order-management system, now slated for May 2027. The continued strength of comparable written sales and client-deposit growth will be the clearest leading indicators of whether demand momentum can translate into sustained profitability and margin recovery.
I often turn to Tickeron’s AI Screener when evaluating how names like ARHS stack up against peers on technical patterns and fundamentals. It helps surface relevant filters quickly so I can focus on the setups that match my criteria without spending hours on manual screening. The tool has become a regular part of how I cross-check ideas before digging deeper into earnings or guidance details.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for ARHS turned positive on October 19, 2026. Looking at past instances where ARHS's MACD turned positive, the stock continued to rise in 33 of 37 cases over the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on ARHS as a result. In 67 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
Following a +6.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARHS advanced for three days, in 246 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 175 of 234 cases where ARHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
ARHS broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.420) is normal, around the industry mean (2.276). P/E Ratio (25.880) is within average values for comparable stocks, (17.269). ARHS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.159). Dividend Yield (0.108) settles around the average of (0.094) among similar stocks. P/S Ratio (0.724) is also within normal values, averaging (1.057).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ARHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry SpecialtyStores